BHST Bioharvest Sciences Inc.

Fundamentals / CIK 0001723464 / USD

Bioharvest Sciences Inc. reported $34.51M in revenue and a net loss of $11.13M for the fiscal year ended December 31, 2025 (up 37.0% year over year), with a 59.3% gross margin and a -16.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BHST in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$35.37M$17.69M$0-$15.01MFY 2023 Revenue: $12.67MFY 2023 Net Income: -$12.56M2023FY 2024 Revenue: $25.19MFY 2024 Net Income: -$12.91M2024FY 2025 Revenue: $34.51MFY 2025 Net Income: -$11.13M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $34.51M $25.19M $12.67M
Cost of Revenue $14.03M $11.25M $7.04M
Gross Profit $20.48M $13.94M $5.63M
Research & Development $5.31M $4.80M $3.37M
Selling, General & Admin $20.74M $16.13M $12.23M
Total Operating Expenses $26.05M $20.93M $15.60M
Operating Income -$5.58M -$6.99M -$9.97M
EBITDA -$3.95M -$5.74M -$9.13M
Income Before Tax -$11.06M -$12.90M -$12.56M
Income Tax Expense -$76K -$8.0K $0
Net Income -$11.13M -$12.91M -$12.56M
Basic EPS -$0.60 -$0.80 -$0.93

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly income statement rows are available in SEC EDGAR CompanyFacts for BHST.

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $23.02M $2.39M $5.36M
Cash & Short-Term Investments $23.02M $2.39M $5.36M
Accounts Receivable, Net $1.98M $1.12M $808K
Inventory $4.56M $3.65M $2.47M
Total Current Assets $30.50M $7.86M $9.05M
Property, Plant & Equipment, Net $8.33M $7.75M $3.93M
Total Non-Current Assets $17.16M $17.14M $5.95M
Total Assets $47.66M $25.00M $15.00M
Accounts Payable $2.63M $3.52M $1.78M
Short-Term Debt $149K $3.90M $0
Other Current Liabilities $452K $1.14M $0
Total Current Liabilities $7.68M $14.26M $26.47M
Other Non-Current Liabilities $1.98M $272K $1.96M
Total Non-Current Liabilities $14.53M $9.41M $3.39M
Total Liabilities $22.22M $23.67M $29.86M
Total Debt (incl. Leases) $10.28M $13.05M $1.43M
Retained Earnings -$107.6M -$96.42M -$83.50M
Total Stockholders' Equity $25.45M $1.33M -$14.85M
Total Equity $25.45M $1.33M -$14.85M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-12-31 2024-12-31 2023-12-31
Cash & Cash Equivalents $23.02M $2.39M $5.36M
Cash & Short-Term Investments $23.02M $2.39M $5.36M
Accounts Receivable, Net $1.98M $1.12M $808K
Inventory $4.56M $3.65M $2.47M
Total Current Assets $30.50M $7.86M $9.05M
Property, Plant & Equipment, Net $8.33M $7.75M $3.93M
Total Non-Current Assets $17.16M $17.14M $5.95M
Total Assets $47.66M $25.00M $15.00M
Accounts Payable $2.63M $3.52M $1.78M
Short-Term Debt $149K $3.90M $0
Other Current Liabilities $452K $1.14M $0
Total Current Liabilities $7.68M $14.26M $26.47M
Other Non-Current Liabilities $1.98M $272K $1.96M
Total Non-Current Liabilities $14.53M $9.41M $3.39M
Total Liabilities $22.22M $23.67M $29.86M
Total Debt (incl. Leases) $10.28M $13.05M $1.43M
Retained Earnings -$107.6M -$96.42M -$83.50M
Total Stockholders' Equity $25.45M $1.33M -$14.85M
Total Equity $25.45M $1.33M -$14.85M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$11.13M -$12.91M -$12.56M
Depreciation & Amortization $1.62M $1.25M $840K
Stock-Based Compensation -- $601K $563K
Change in Receivables -$865K -$308K -$262K
Change in Inventory -$904K -$1.19M -$1.09M
Operating Cash Flow -$7.23M -$6.68M -$8.52M
Capital Expenditure -$2.35M -$2.83M -$1.47M
Free Cash Flow -$9.58M -$9.52M -$10.00M
Investing Cash Flow -$2.37M -$3.03M -$1.47M
Common Stock Issued $18.26M $0 $0
Financing Cash Flow $30.19M $6.78M $13.56M
Net Change in Cash $20.60M -$2.93M $3.56M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

No quarterly cash flow statement rows are available in SEC EDGAR CompanyFacts for BHST.

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Gross Margin 59.3% 55.4% 44.5%
Operating Margin -16.2% -27.7% -78.6%
Net Profit Margin -32.3% -51.3% -99.1%
Return on Equity (ROE) -43.8% -970.9% --
Return on Assets (ROA) -23.4% -51.6% -83.7%
Current Ratio 3.97x 0.55x 0.34x
Quick Ratio 3.38x 0.29x 0.25x
Debt to Equity 0.40x 9.81x --
Revenue Growth (YoY) +37.0% +98.8% --
Gross Profit Growth (YoY) +46.9% +147.5% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

No quarterly ratios & growth rows are available in SEC EDGAR CompanyFacts for BHST.
Source: SEC EDGAR CompanyFacts (CIK 0001723464) · from December 31, 2023 Data through December 31, 2025 · synced Nov 21, 2026, 05:01 UTC · Open in terminal